Literature DB >> 10531491

Purification, solution properties and crystallization of SIV integrase containing a continuous core and C-terminal domain.

Y Li1, Y Yan, J Zugay-Murphy, B Xu, J L Cole, M Witmer, P Felock, A Wolfe, D Hazuda, M K Sardana, Z Chen, L C Kuo, V V Sardana.   

Abstract

The C-terminal two-thirds segment of integrase derived from the simian immunodeficiency virus has been cloned, expressed in Escherichia coli, and purified to greater than 95% homogeneity. The protein encompasses amino-acid residues 50-293 and contains a F185H substitution to enhance solubility. In dilute solutions at concentrations below 1 mg ml(-1), the enzyme is predominantly dimeric. At the higher concentrations (>10 mg ml(-1)) required to enable crystallization, the enzyme self-associates to form species with molecular weights greater than 200 kDa. Despite the apparent high aggregation in solution, the enzyme crystallizes from a 8%(v/v) polyethylene glycol (molecular weight 6000) solution in a form suitable for X-ray diffraction studies. The resulting single crystals belong to the space group P2(1)2(1)2(1), with unit-cell parameters a = 79.76, b = 99.98, c = 150.2 A, alpha = beta = gamma = 90 degrees and Z = 4. Under X-ray irradiation generated with a rotating-anode generator, the crystals diffract to 2.8 A resolution and allow collection of a native 3 A resolution diffraction data set.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531491     DOI: 10.1107/s0907444999009610

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  4 in total

1.  Characterization of the Drug Resistance Profiles of Integrase Strand Transfer Inhibitors in Simian Immunodeficiency Virus SIVmac239.

Authors:  Said A Hassounah; Yannan Liu; Peter K Quashie; Maureen Oliveira; Daniela Moisi; Bluma G Brenner; Paul A Sandstrom; Thibault Mesplède; Mark A Wainberg
Journal:  J Virol       Date:  2015-09-16       Impact factor: 5.103

2.  A directed approach to improving the solubility of Moloney murine leukemia virus reverse transcriptase.

Authors:  D Das; M M Georgiadis
Journal:  Protein Sci       Date:  2001-10       Impact factor: 6.725

3.  Differential multimerization of Moloney murine leukemia virus integrase purified under nondenaturing conditions.

Authors:  Rodrigo A Villanueva; Colleen B Jonsson; Jennifer Jones; Millie M Georgiadis; Monica J Roth
Journal:  Virology       Date:  2003-11-10       Impact factor: 3.616

4.  Surface patches on recombinant erythropoietin predict protein solubility: engineering proteins to minimise aggregation.

Authors:  M Alejandro Carballo-Amador; Edward A McKenzie; Alan J Dickson; Jim Warwicker
Journal:  BMC Biotechnol       Date:  2019-05-09       Impact factor: 2.563

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.